Abstract:Background: Neuronal abnormalities are closely associated with major depressive disorder (MDD). Available evidence suggests a role for microRNAs (miRNAs) in regulating the expression of genes involved in MDD. Hence, miRNAs that can be potential therapeutic targets need to be identified. Methods: A mouse model of chronic unpredictable stress (CUS) was used to evaluate the function of miRNAs in MDD. miR-144-5p was screened from the hippocampi of CUS mice based on sequencing results. Adenovirus-associated vectors were used to overexpress or knockdown miR-144-5p in mice. BpV(pic) and LY294002 were used to determine the relationship between miR-144-5p target genes PTEN and TLR4 in neuronal impairment caused by miR-144-5p deficiency. Western blotting, immunofluorescence, ELISA immunosorbent assay, and Golgi staining were used to detect neuronal abnormalities. Serum samples from healthy individuals and patients with MDD were used to detect miR-144-5p levels in the serum and serum exosomes using qRT-PCR. Results: miR-144-5p expression was significantly decreased within the hippocampal dentate gyrus (DG) of CUS mice. Upregulation of miR-144-5p in the DG ameliorated depression-like behavior in CUS mice and attenuated neuronal abnormalities by directly targeting PTEN and TLR4 expression. Furthermore, miR-144-5p knockdown in normal mice led to depression-like behavior via inducing neuronal abnormalities, including abnormal neurogenesis, neuronal apoptosis, altered synaptic plasticity, and neuroinflammation. miR-144-5p deficiency-mediated neuronal impairment was mediated by PI3K/Akt/FoxO1 signaling. Furthermore, miR-144-5p levels were downregulated in the sera of patients with MDD and associated with depressive symptoms. Consistently, serum exosome-derived miR-144-5p levels were decreased in patients with MDD. Conclusion: miR-144-5p plays a vital role in regulating neuronal abnormalities in depression. Our findings provide translational evidence that miR-144-5p is a new potential therapeutic target for MDD.

Reduced cerebral cortex thickness is related to overexpression of exosomal miR-146a-5p in medication-free patients with major depressive disorder

565 – Abnormality of White Matter Structure and Resting State Brain Function in First-Episode, Treatment-Naive Patients with Major Depressive Disorder

Increased Plasma Levels of IL-6 Are Associated with Striatal Structural Atrophy in Major Depressive Disorder Patients with Anhedonia

Exosomal miR-1202 mediates Brodmann Area 44 functional connectivity changes in medication-free patients with major depressive disorder: An fMRI study

Abnormal Expression Profile of Plasma-Derived Exosomal Micrornas in Patients with Treatment-Resistant Depression

Clinical and preclinical evaluation of miR-144-5p as a key target for major depressive disorder

Exosomes from Patients with Major Depression Cause Depressive-Like Behaviors in Mice with Involvement of Mir-139-5p-regulated Neurogenesis.

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Alterations of white matter integrity in adults with major depressive disorder: a magnetic resonance imaging study.

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

Cortical Thickness and White Matter Integrity Abnormalities in Obsessive-Compulsive Disorder: A Combined Multimodal Surface-Based Morphometry and Tract-Based Spatial Statistics Study

MicroRNA132 associated multimodal neuroimaging patterns in unmedicated major depressive disorder.

Altered patterns of association between cortical thickness and subcortical volume in patients with first episode major depressive disorder: A structural MRI study.

Differential and unique patterns of synaptic miRNA expression in dorsolateral prefrontal cortex of depressed subjects

Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: A multimodal imaging study

Regional decreases of cortical thickness in major depressive disorder and their correlation with illness duration: a case-control study

Cortical thickness reductions associate with brain network architecture in major depressive disorder

Down-regulated miR-16-2 in peripheral blood is positively correlated with decreased bilateral insula volume in patients with major depressive disorder

Increased Expression of a Novel Mirna in Peripheral Blood is Negatively Correlated with Hippocampal Volume in Patients with Major Depressive Disorder.

The Microrna-195 - BDNF Pathway and Cognitive Deficits in Schizophrenia Patients with Minimal Antipsychotic Medication Exposure

Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression